D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Fox Class B
FOX
$20.7B
| $240K | ﹤0.01% |
+6,688
| New | +$255K |
|
3277
Hamilton Beach Brands
HBB
$302M
| $240K | ﹤0.01% |
11,171
+8
| +0.1% | +$194 |
|
3278
Nokia
NOK
$50.8B
| $239K | ﹤0.01% |
41,843
-10,621,606
| -100% | -$65M |
|
3279
Viridian Therapeutics
VRDN
$2.13B
| $239K | ﹤0.01% |
5,710
+1,770
| +45% | +$80.1K |
|
3280
Verastem
VSTM
$532M
| $239K | ﹤0.01% |
6,721
-38,272
| -85% | -$1.51M |
|
3281
CALL
Corning
GLW
$126B
| $238K | ﹤0.01% |
+7,200
| New | +$236K |
|
|
SUP
3282
PUT
DELISTED
Superior Industries International
SUP
| $238K | ﹤0.01% |
50,000
| – | – |
|
3283
Power Integrations
POWI
$3.54B
| $237K | ﹤0.01% |
6,788
-3,190
| -32% | -$108K |
|
|
RDS.B
3284
CALL
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $237K | ﹤0.01% |
+3,700
| New | +$234K |
|
|
SINA
3285
CALL
DELISTED
Sina Corp
SINA
| $237K | ﹤0.01% |
4,000
-6,000
| -60% | -$360K |
|
|
NLSN
3286
PUT
DELISTED
Nielsen Holdings plc
NLSN
| $237K | ﹤0.01% |
+10,000
| New | +$259K |
|
|
TOUR
3287
Tuniu
TOUR
$55.4M
| $236K | ﹤0.01% |
4,923
-254
| -5% | -$12.4K |
|
|
AIG.WS
3288
DELISTED
American International Group, Inc.
AIG.WS
| $236K | ﹤0.01% |
41,284
| – | – |
|
3289
PUT
Intuit
INTU
$81.1B
| $235K | ﹤0.01% |
+900
| New | +$208K |
|
3290
CRISPR Therapeutics
CRSP
$4.58B
| $234K | ﹤0.01% |
6,552
-18,160
| -73% | -$628K |
|
3291
Rigel Pharmaceuticals
RIGL
$680M
| $234K | ﹤0.01% |
9,103
-2,228
| -20% | -$50.9K |
|
3292
PUT
SM Energy
SM
$7.96B
| $234K | ﹤0.01% |
+13,400
| New | +$238K |
|
3293
Descartes Systems
DSGX
$5.84B
| $233K | ﹤0.01% |
6,400
-19,600
| -75% | -$634K |
|
3294
CALL
MKS Inc
MKSI
$22.2B
| $233K | ﹤0.01% |
+2,500
| New | +$202K |
|
|
SCWX
3295
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $232K | ﹤0.01% |
12,606
+600
| +5% | +$11.7K |
|
3296
Cars.com
CARS
$641M
| $231K | ﹤0.01% |
+10,147
| New | +$245K |
|
3297
Provident Financial Services
PFS
$3.11B
| $231K | ﹤0.01% |
8,939
-4,307
| -33% | -$113K |
|
3298
Brighthouse Financial
BHF
$3.63B
| $228K | ﹤0.01% |
6,290
-9,262
| -60% | -$347K |
|
3299
Liberty Latin America Class C
LILAK
$1.5B
| $228K | ﹤0.01% |
13,691
| – | – |
|
3300
Artivion
AORT
$1.23B
| $227K | ﹤0.01% |
7,779
-1,875
| -19% | -$53.5K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.